WOBURN, Mass.--(BUSINESS WIRE)--ArQule, Inc. (NASDAQ: ARQL) today announced its financial results for the second quarter of 2007. For the quarter ended June 30, 2007, the Company reported a net loss of $13,361,000 or $0.36 per share, compared with a net loss of $7,574,000, or $0.21 per share, for the second quarter of 2006. For the six-month period ended June 30, 2007, the Company reported a net loss of $27,865,000, or $0.77 per share, compared to a net loss of $3,288,000, or $0.09 per share, for the six-month period ended June 30, 2006. Increased losses in the 2007 periods relate primarily to increased research and development costs incurred in connection with clinical trials.